Mortality in children with positive SARS-CoV-2 polymerase chain reaction test: Lessons learned from a tertiary referral hospital in Indonesia

Background: The incidence of coronavirus disease 2019 (COVID-19) is still increasing rapidly, but little is known about the prevalence and characteristics of fatal cases in children in Indonesia. This study aimed to describe the characteristics of children with COVID-19 with fatal outcomes in a tertiary referral hospital in Indonesia. Methods: This cross-sectional study used data collected from the medical records of patients with COVID-19 admitted to Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia from March to October 2020. Results: During the study period, 490 patients were admitted and diagnosed with suspected and probable COVID-19. Of these patients, 50 (10.2%) were confirmed to have COVID-19, and 20 (40%) had a fatal outcome. The fatality rate was higher in patients aged ≥10 years, categorized with severe disease upon admission, PaO2/FiO2 ratio ≤300 mmHg and chronic underlying diseases. The most common clinical manifestations were generalized symptoms, while acute respiratory distress syndrome (8/20) and septic shock (7/20) were the two most common causes of death. Increased procalcitonin, D-dimer, lactate dehydrogenase and presepsin levels were found in all fatal cases. One patient met the criteria of multisystem inflammatory syndrome in children. Conclusion: Our work highlights the high mortality rate in paediatric patients with positive SARS-CoV-2 polymerase chain reaction test. These findings might be related to or co-incided with COVID-19 infection. Further studies are needed to improve understanding of the role of severe acute respiratory syndrome coronavirus-2 in elaborating the mechanisms leading to death in children with comorbidities..

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:107

Enthalten in:

International Journal of Infectious Diseases - 107(2021), Seite 78-85

Sprache:

Englisch

Beteiligte Personen:

Rismala Dewi [VerfasserIn]
Nastiti Kaswandani [VerfasserIn]
Mulya Rahma Karyanti [VerfasserIn]
Darmawan Budi Setyanto [VerfasserIn]
Antonius Hocky Pudjiadi [VerfasserIn]
Aryono Hendarto [VerfasserIn]
Mulyadi M. Djer [VerfasserIn]
Ari Prayitno [VerfasserIn]
Irene Yuniar [VerfasserIn]
Wahyuni Indawati [VerfasserIn]
Yogi Prawira [VerfasserIn]
Setyo Handryastuti [VerfasserIn]
Hikari Ambara Sjakti [VerfasserIn]
Eka Laksmi Hidayati [VerfasserIn]
Dina Muktiarti [VerfasserIn]
Amanda Soebadi [VerfasserIn]
Niken Wahyu Puspaningtyas [VerfasserIn]
Riski Muhaimin [VerfasserIn]
Anisa Rahmadhany [VerfasserIn]
Gilbert Sterling Octavius [VerfasserIn]
Henny Adriani Puspitasari [VerfasserIn]
Madeleine Ramdhani Jasin [VerfasserIn]
Tartila Tartila [VerfasserIn]
Nina Dwi Putri [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.sciencedirect.com [kostenfrei]
Journal toc [kostenfrei]

Themen:

COVID-19
Children
Indonesia
Infectious and parasitic diseases
Outcome
SARS-CoV-2

doi:

10.1016/j.ijid.2021.04.019

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ001216783